Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients

(2011) Daniel C. Baumgart et al.   INFLAMMATORY BOWEL DISEASES

Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn’s disease

(2011) Martin Tichy et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Infliximab-induced Psoriasis in Children With Inflammatory Bowel Disease

(2011) Girish Hiremath et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Psoriatic Skin Lesions Induced by Certolizumab Pegol

(2010) Rhonda Q. Klein et al.   ARCHIVES OF DERMATOLOGY

Infliximab-Induced Psoriaform Rash

(2010) Jonathan Goldstein et al.   Clinical Gastroenterology and Hepatology

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

(2010) Jean–François Rahier et al.   Clinical Gastroenterology and Hepatology

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab

(2010) F. Medkour et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

(2010) Marisa Iborra et al.   Journal of Crohns & Colitis

Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease

(2010) Laurie S. Conklin et al.   Nature Reviews Gastroenterology & Hepatology

Occurrence of Pustular Psoriasis after Treatment of Crohn Disease with Infliximab

(2010) CRYSTAL POURCIAU et al.   PEDIATRIC DERMATOLOGY

Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis

(2010) Angelique N. Collamer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

(2009) G. FIORINO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

(2009) Uwe Wollina et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Severe Cutaneous Psoriasis After Certolizumab Pegol Treatment: Report of a Case

(2009) Filippo Mocciaro et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

(2008) Justin M. Ko et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis

(2008) Rajan P. Nair et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

(2007) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY